Rare Conversations invites you for the inaugural episode of the new Rare Conversations event series in 2022, aimed at powering the next decade of rare disease innovation in Europe. The first episode will be focused on game-changing opportunities for the R&D community to address existing challenges in rare diseases. The aim is to understand what is the basis needed to build the foundations for the future innovative rare disease ecosystem.
The webinar will take place on April 6th from 14.00 – 15.15 CET.
The event, organized by Alexion, AstraZeneca Rare Disease, in cooperation with the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), will revolve around discussions on how the revision of the OMP Regulation can create a space for opportunities for scientific progress.
More information and registration here: https://www.eucope.org/events/rare-conversations-2022-game-changing-opportunities-for-the-rd-community-to-address-existing-challenges-in-rare-diseases/